PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

SwRI develops novel DNA-targeting therapeutic screening technique

Advanced application efficiently assesses new treatment possibilities, particularly for cancer

SwRI develops novel DNA-targeting therapeutic screening technique
2024-08-19
(Press-News.org) SAN ANTONIO — August 19, 2024 —Southwest Research Institute (SwRI) has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases. Combining SwRI’s 3D drug screening software tool and machine learning techniques, SwRI scientists successfully predicted the DNA binding affinity and cancer cell toxicity for a variety of relevant drug compounds under development.

SwRI expanded the capabilities of its Rhodium™ drug development tool to visualize and rapidly predict how DNA-targeting therapeutics can attack cancer cells as well other diseases. According to the World Health Organization, cancer is a leading cause of death worldwide, responsible for one in six deaths globally. Chemotherapy uses a combination of drugs to slow or stop the growth and spread of cancer cells and shrink tumors. Many of these chemotherapeutics directly target DNA, which can damage the DNA in healthy cells and cause severe side effects, medical complications and even secondary cancers. While a number of drug development platforms and machine learning methods virtually screen drugs that target proteins, few methods exist for screening drugs that target DNA. SwRI has now successfully demonstrated a virtual screening application to design more effective DNA-targeting therapeutics to combat different types of cancer and infectious diseases.

“Cancer cells often have damaged DNA repair machinery and replicate much faster than healthy cells, which makes DNA a viable target for selective cancer treatment,” said Dr. Tristan Adamson, a research scientist in SwRI’s Pharmaceutical and Bioengineering Department. “SwRI has successfully developed and validated a powerful technique to use Rhodium™ for drug development campaigns that directly target DNA in oncology research for leukemia, breast cancer, liver cancer and more.”

Dillon Cao, an SwRI scientist working with Adamson, added, “We want to make drug compounds more selective to target a patient’s DNA for maximum efficacy while at the same time enabling scientists to prune away some of the drug toxicities.”

In an internally funded research project, SwRI scientists developed several machine learning training sets, each serving important roles in screening potential DNA-targeting oncology drugs. These models have been validated using statistical tests and correlated with published experimental data. SwRI scientists accurately predicted the effectiveness of drug compounds against several cancer cell models using the training sets and SwRI’s Rhodium™ virtual screening tool. They now plan to apply this software in future drug development programs to design next-generation cancer therapeutics.

SwRI used internal funding to develop Rhodium™ software to provide a computer-aided tool to rapidly screen possible treatment methods to combat infectious diseases and chemical warfare agents. SwRI’s machine learning capabilities can evaluate more than 2 million drug compounds in just a few days to identify compounds with high probability for successful treatment with minimal adverse side effects. SwRI has used Rhodium™ to successfully identify highly potent therapeutics for several infectious diseases, such as SARS-CoV-2 (commonly referred to as COVID-19) and hemorrhagic fevers, as well as chemical nerve agent antidotes.

SwRI has more than 75 years of pharmaceutical research and development experience including virtual drug design, medicinal chemistry, formulation, microencapsulation, process development and synthesis scale-up. SwRI’s Chemistry and Chemical Engineering Division is ISO 9001:2015 certified, meeting international quality standards for product development from initial design through Current Good Manufacturing Practice (CGMP) scale up and clinical supplies. SwRI scientists support drug development from discovery to clinical trials in FDA-inspected CGMP facilities.

For more information, visit https://www.swri.org/industries/pharmaceutical-development.

END

[Attachments] See images for this press release:
SwRI develops novel DNA-targeting therapeutic screening technique SwRI develops novel DNA-targeting therapeutic screening technique 2

ELSE PRESS RELEASES FROM THIS DATE:

Swiping through online videos increases boredom, study finds

2024-08-19
Swiping through online videos to relieve boredom may actually make people more bored and less satisfied or engaged with the content, according to research published by the American Psychological Association.    The study included seven experiments with a total of more than 1,200 participants from the United States or college students at the University of Toronto. In two baseline experiments, participants switched from one online video to the next when they were bored, and they predicted they would feel less bored by switching videos instead ...

Kelvin K. Droegemeier on ‘Working Toward a Computational Framework to Support Earth System Science and Climate Projection’

2024-08-19
Editor’s note: NCSA is cohosting an International Summit on a Computational System for Frontier Earth System Science and Climate Simulation & Projection September 29 through October 2, 2024 at the University of Illinois Urbana-Champaign. Toward a Computational Framework for Earth System Models at Kilometer Resolution to Support Earth System Science and Climate Projection By Kelvin K. Droegemeier, Professor of Atmospheric Science and Special Advisor to the Chancellor for Science and Policy at the University of Illinois Urbana-Champaign Almost daily, and often without realizing it, we rely upon computers to guide our decisions. Whether finding the fastest ...

National Academy of Medicine selects FAU for substance use, opioid crises collaborative

National Academy of Medicine selects FAU for substance use, opioid crises collaborative
2024-08-19
As of 2024, approximately 2.7 million Americans aged 12 and older were estimated to have misused prescription opioids in the past year. Moreover, alcohol, cannabis, cocaine, methamphetamines, among other substances, reflect a complex landscape that requires ongoing efforts aimed at prevention, treatment and policy changes to address the various issues associated with each substance. Florida Atlantic University was recently selected to participate in the National Academy of Medicine’s (NAM) Action Collaborative on Combatting Substance Use Opioid Crises Core Competency Implementation Pilot Project. To improve coordination ...

Study finds potential link between DNA markers and aging process

2024-08-19
Researchers at Weill Cornell Medicine and the epigenetics company TruDiagnostic have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age. The results support the idea that certain retroelements in the human genome may be involved in aging. Retroelements have been known to impact gene regulation, gene expression, genomic stability and the trajectory of various human diseases, but their potential as biomarkers for aging had been largely unexplored. The ...

Improving access to heart-failure screening with saliva

Improving access to heart-failure screening with saliva
2024-08-19
DENVER, Aug. 19, 2024 — Heart failure is a leading cause of death worldwide and is especially fatal for people who don’t have access to medical facilities. So, a team of researchers aims to bring heart failure screening from the lab to the home. Their point-of-care electrochemical biosensor prototype, which resembles a see-through lateral flow test for COVID-19, can measure levels of two biomarkers for heart failure in as little as 15 minutes from just a drop of saliva. Trey Pittman, a graduate student at Colorado State University, will present his team’s research at the fall meeting of the American Chemical Society (ACS). ACS Fall 2024 is a hybrid ...

Expanding a child’s heart implant with light

Expanding a child’s heart implant with light
2024-08-19
DENVER, Aug. 19, 2024 — Children born with defects that impair the heart’s lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic tube called a shunt to improve blood flow. However, as children grow, the shunt is often replaced to accommodate their changing bodies. Now, researchers have designed a shunt that expands when activated by light. If developed successfully, this device could reduce the number of open-chest surgeries these children receive. The researchers will present their results at the fall meeting of the American Chemical Society (ACS). ACS Fall 2024 ...

New insights on how bird flu crosses the species barrier

New insights on how bird flu crosses the species barrier
2024-08-19
In recent years, public health measures, surveillance, and vaccination have helped bring about significant progress in reducing the impact of seasonal flu epidemics, caused by human influenza viruses A and B. However, a possible outbreak of avian influenza A (commonly known as ‘bird flu’) in mammals, including humans, poses a significant threat to public health.  The Cusack group at EMBL Grenoble studies the replication process of influenza viruses. A new study from this group sheds light on the different mutations that the avian influenza virus can undergo to be able to replicate in mammalian cells.  Some avian influenza ...

Energy companies pressure landowners into fracking, study shows

Energy companies pressure landowners into fracking, study shows
2024-08-19
BINGHAMTON, N.Y. -- Energy companies use persistent and personalized pressure to get landowners to give permission for hydraulic fracturing (fracking), and even when landowners decline, companies use legalized compulsion to conduct fracking anyway, according to a new study led by researchers at Binghamton University, State University of New York and UNLV. “Hydraulic fracturing is a controversial issue, but a lot of the controversy has been focused on the big-picture consequences, for the climate and the economy,” said Benjamin Farrer, lead author and former PhD student at Binghamton University. “One of our hopes for this paper is that it will encourage policymakers ...

UC Irvine team says urban street networks, building density shape severity of floods

2024-08-19
Irvine, Calif., Aug. 19, 2024 — Cities around the globe are experiencing increased flooding due to the compounding effects of stronger storms in a warming climate and urban growth. New research from the University of California, Irvine suggests that urban form, specifically the building density and street network of a neighborhood, is also affecting the intensity of flooding. For a paper published today in Nature Communications, researchers in UC Irvine’s Department of Civil and Environmental Engineering turned to statistical mechanics ...

Nurses play key role in addressing mental well-being for people after a stroke

2024-08-19
Statement Highlights: The latest research indicates that 16% to 85% of people recovering from a stroke experience at least one psychosocial symptom, including depression, anxiety, stress, fatigue and/or decreased quality of life. Critical nursing interventions, such as regular mental health screenings, education, symptom management and follow-up care, are key to reducing the negative effects on a patient’s mental well-being after a stroke, yet only a small proportion of patients receive treatment. ...

LAST 30 PRESS RELEASES:

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

New light on toxicity of Bluefin tuna

Menopause drug reduces hot flashes by more than 70%, international clinical trial finds

FGF21 muscle hormone associated with slow ALS progression and extended survival

Hitting the right note: The healing power of music therapy in the cardiac ICU

Cardiovascular disease risk rises in Mexico, despite improved cholesterol control

Flexible optical touch sensor simultaneously pinpoints pressure strength and location

Achalasia diagnosis simplified to AI plus X-ray

PolyU scholars pioneer smart and sustainable personal cooling technologies to address global extreme heat

NIH grant aims for childhood vaccine against HIV

Menstrual cycle and long COVID: A relation confirmed

WMO report on global water resources: 2024 was characterized by both extreme drought and intense rainfall

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

Thermal trigger

SNU materials science and engineering team identifies reconstruction mechanism of copper alloy catalysts for CO₂ conversion

[Press-News.org] SwRI develops novel DNA-targeting therapeutic screening technique
Advanced application efficiently assesses new treatment possibilities, particularly for cancer